InnovationMedical DeviceNews

Siemens Healthineers introduces Corindus in India

The robotic cardiovascular interventions can aid significantly by contributing to cardiovascular medical conditions like heart diseases

Siemens Healthineers has launched Corindus CorPath GRX, the only FDA cleared and CE certified robotic system, for coronary and peripheral vascular interventions in India. With state-of-the-art technology, the company has opened a new field for advanced therapies business, tapping into adjacent growth markets with great potential for the future. 


Robotic systems for minimally invasive procedures help doctors to precisely control guide catheters, guide wires, balloon or stent implants via integrated imaging. The physician does not have to stand at the angiography table as usual but can control the procedure with a separate controlling module and is therefore protected from radiation. Recent studies have shown that the CorPath GRX robot system facilitates up to 20 per cent reduction in radiation dose to patients.

The robotic cardiovascular interventions can aid significantly by contributing to cardiovascular medical conditions like heart diseases, where the ideal treatment include complex procedures in the coronary arteries by specialised medical professionals. The smart procedural automation can enable performing complex interventional cases in a shorter time, with precision, and with better clinical outcomes. Adoption of robotics in the surgical intervention will provide an enormous impetus to the Indian healthcare sector.

Possibilities of remote treatment in the near future(currently under approval) could address the key geographical challenges of limited availability of specialists and corresponding clinical facilities for minimally invasive procedures in many regions. With Corindus technology, Siemens Healthineers is well-positioned to be the leading player in the field of robotic vascular interventions.

“Together with our strong portfolio in medical imaging, digitalisation and artificial intelligence, we are creating significant synergies to advance therapy outcomes. The interplay of protection, precision and standardisation through robotic-assisted interventions will allow the cardiologists to perform complex procedures faster and better. This will allow specialists to improve procedural quality and expand precision medicine; thereby improving clinical outcomes for the patient,” said Sanjay David, Head of Advanced Therapies, Siemens Healthineers, India. 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.


Related Articles

Leave a Reply

Back to top button